Histologic response to OKT3 therapy for hepatic allograft rejection.
Rohrer
R J
RJ
Department of Surgery, New England Deaconess Hospital, Boston, MA 02215.
Jenkins
R L
RL
Khettry
U
U
Benotti
P N
PN
Dodson
T F
TF
Karlson
C G
CG
Georgi
B A
BA
Monaco
A P
AP
D000469:Alkaline Phosphatase / Q000097:blood; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D015337:Multicenter Studies as Topic; D011897:Random Allocation; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001379:Azathioprine